TrialHuman gene therapy2011

Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results.

Terence R Flotte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.